| Sajatovic, Martha |
NCT06346262: Seizure Rescue Medication (RM) As Part of a Comprehensive Epilepsy Self-management Package of Care |
|
|
| Recruiting | 4 | 43 | US | SMART RM, Valtoco Nasal Product | University Hospitals Cleveland Medical Center | Epilepsy | 01/26 | 01/26 | | |
| Completed | N/A | 36 | US | Customized Adherence Enhancement for Adolescents and Young Adults (CAE-AYA), Enhanced Treatment as Usual (ETAU) | Case Western Reserve University | Bipolar Disorder | 09/23 | 09/23 | | |
| Recruiting | N/A | 160 | US | TargEted MAnageMent Intervention (TEAM) | Case Western Reserve University, National Institute of Nursing Research (NINR) | Stroke, Transient Ischemic Attack | 09/25 | 09/25 | | |
SMART, NCT06139198: Self-management Intervention for Reducing Epilepsy Burden Among Ugandans With Epilepsy. |
|
|
| Not yet recruiting | N/A | 188 | NA | Self-MAnagement intervention for Reducing The epilepsy burden among Ugandans | Makerere University, Case Western Reserve University, Children's Hospital Medical Center, Cincinnati, Mbarara University of Science and Technology | Epilepsy | 07/27 | 07/28 | | |
| Completed | N/A | 160 | US | SMART 2 | Mark A. Granner, Centers for Disease Control and Prevention | Epilepsy | 12/24 | 12/24 | | |
| Recruiting | N/A | 190 | US | Customized Adherence Enhancement (CAE), Enhanced Treatment as Usual (eTAU) | Case Western Reserve University, National Institute of Mental Health (NIMH) | Bipolar Disorder | 11/25 | 05/26 | | |
iTAB-CV RCT, NCT04675593: Using MHealth to Improve Adherence and Reduce Blood Pressure in Individuals with Hypertension and Mood Disorders |
|
|
| Recruiting | N/A | 200 | US | iTAB-CV, Self-Monitoring | Case Western Reserve University, University of California, San Diego, National Heart, Lung, and Blood Institute (NHLBI) | Bipolar Disorder, Non-Adherence, Medication, Hypertension, Major Depressive Disorder | 10/25 | 06/26 | | |
| Recruiting | N/A | 36 | US | Customized Adherence Enhancement for Schizophrenia (CAE-S), Enhanced Treatment as Usual (eTAU) | Martha Sajatovic, Merck Sharp & Dohme LLC | Schizophrenia | 04/25 | 04/25 | | |
| Reed, John H |
NCT05706506: A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2) |
|
|
| Completed | 4 | 152 | US | Tirzepatide, LY3298176 | Eli Lilly and Company | Type 2 Diabetes, Diabetes Mellitus, Type 2 | 10/23 | 10/23 | | |
ATTAIN-2, NCT05872620: A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes |
|
|
| Active, not recruiting | 3 | 1500 | Europe, US, RoW | Orforglipron, LY3502970, Placebo | Eli Lilly and Company | Obesity, Overweight, Type 2 Diabetes | 08/25 | 08/25 | | |
OPTI-2, NCT06238778: Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec |
|
|
| Recruiting | 2 | 230 | US | HDV-Lispro, HDV-L, Lispro, LIS | Diasome Pharmaceuticlas, Inc. | Diabetes Mellitus, Type 1 | 06/25 | 12/25 | | |
| Completed | 2 | 265 | Europe, Canada, US, RoW | INV-202, None applicable, Placebo | Inversago Pharma Inc., Worldwide Clinical Trials | Diabetic Kidney Disease | 08/24 | 09/24 | | |
NCT04809285: Use of the Guardian™ Connect System With Smart Connected Devices |
|
|
| Completed | N/A | 217 | US | Guardian™ Connect system, InPen™ Basal smart cap, smart insulin pens, and InPen™ Diabetes Management app | Medtronic Diabetes | Type 1 Diabetes Mellitus | 09/23 | 09/23 | | |
| Completed | N/A | 343 | US | Omnipod 5 Automated Glucose Control System | Insulet Corporation, Jaeb Center for Health Research | Type2 Diabetes | 03/24 | 03/24 | | |
NCT05325294: Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev® |
|
|
| Completed | N/A | 244 | US | MiniMed 780G System | Medtronic Diabetes, Eli Lilly and Company | Type 1 Diabetes | 01/24 | 01/24 | | |
NCT05714059: Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM |
|
|
| Completed | N/A | 250 | US | Insulin Pump with Continuous Glucose Monitoring | Medtronic Diabetes | Type 1 Diabetes | 12/23 | 12/23 | | |
NCT02748018: Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home |
|
|
| Active, not recruiting | N/A | 280 | Europe, Canada, US, RoW | 670G and 770G Insulin Pump, Subject's Current Diabetes Therapy | Medtronic Diabetes | Type 1 Diabetes | 03/25 | 06/25 | | |
NCT06273124: Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes |
|
|
| Completed | N/A | 260 | US | SteadiSet Extended Wear Infusion Set | Tandem Diabetes Care, Inc., Jaeb Center for Health Research | Type1diabetes | 12/24 | 12/24 | | |
NCT05238142: In-Home Study with MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults with Insulin-requiring Type 2 Diabetes |
|
|
| Active, not recruiting | N/A | 575 | US | MiniMed™ 780G Insulin Pump system | Medtronic Diabetes | Type 2 Diabetes Treated with Insulin | 01/25 | 02/25 | | |
NCT05224258: Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp® |
|
|
| Completed | N/A | 240 | Canada, US, RoW | MiniMed 780G System | Medtronic Diabetes | Type 1 Diabetes | 06/24 | 06/24 | | |
NCT06452914: Clinical Outcomes Related to Treatment of Distal Symmetric Polyneuropathy Using Semiconductor Embedded Therapeutic Socks |
|
|
| Not yet recruiting | N/A | 80 | NA | Semiconductor Embedded Therapeutic Socks, Placebo Socks | Endocrine Research Solutions, INCREDIWEAR HOLDINGS, INC. | Diabetic Neuropathy | 06/25 | 06/25 | | |
NCT06719531: SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients with Type 1 and Type 2 Diabetes |
|
|
| Not yet recruiting | N/A | 1500 | US | Continuous Glucose Monitoring | Medtronic Diabetes | Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | 12/25 | 12/25 | | |
| Zimmermann, Kari M |
NCT06346262: Seizure Rescue Medication (RM) As Part of a Comprehensive Epilepsy Self-management Package of Care |
|
|
| Recruiting | 4 | 43 | US | SMART RM, Valtoco Nasal Product | University Hospitals Cleveland Medical Center | Epilepsy | 01/26 | 01/26 | | |
| Odugbesan, A Ola |
OPTI-2, NCT06238778: Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec |
|
|
| Recruiting | 2 | 230 | US | HDV-Lispro, HDV-L, Lispro, LIS | Diasome Pharmaceuticlas, Inc. | Diabetes Mellitus, Type 1 | 06/25 | 12/25 | | |
